loadpatents
name:-0.084685087203979
name:-0.026540994644165
name:-0.0035011768341064
Hitoshi; Yasumichi Patent Filings

Hitoshi; Yasumichi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hitoshi; Yasumichi.The latest application filed is for "medicinal composition".

Company Profile
3.25.41
  • Hitoshi; Yasumichi - Kyoto-shi Kyoto JP
  • Hitoshi; Yasumichi - Brisbane CA
  • Hitoshi; Yasumichi - Kyoto JP
  • Hitoshi; Yasumichi - Mountain View CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Medicinal Composition
App 20220233665 - Yasui; Yutaka ;   et al.
2022-07-28
Direct Ampk Activators
App 20220098175 - Shaw; Simon ;   et al.
2022-03-31
Axl Inhibitors For Use In Combination Therapy For Preventing, Treating Or Managing Metastatic Cancer
App 20210379064 - Hitoshi; Yasumichi ;   et al.
2021-12-09
Direct AMPK activators
Grant 11,174,246 - Shaw , et al. November 16, 2
2021-11-16
METHOD FOR PRODUCING REGENERATED T CELL POPULATION VIA iPS CELLS
App 20210238550 - Yasui; Yutaka ;   et al.
2021-08-05
AMPK-activating heterocyclic compounds and methods for using the same
Grant 10,941,134 - Goff , et al. March 9, 2
2021-03-09
Ampk-activating Heterocyclic Compounds And Methods For Using The Same
App 20200017465 - Goff; Dane ;   et al.
2020-01-16
Axl Inhibitors For Use In Combination Therapy For Preventing, Treating Or Managing Metastatic Cancer
App 20190336500 - Hitoshi; Yasumichi ;   et al.
2019-11-07
AMPK-activating heterocyclic compounds and methods for using the same
Grant 10,377,742 - Goff , et al. A
2019-08-13
Methods Of Treating Ibrutinib-resistant Disease
App 20180296579 - Hitoshi; Yasumichi ;   et al.
2018-10-18
Ampk-activating Heterocyclic Compounds And Methods For Using The Same
App 20180057478 - Goff; Dane ;   et al.
2018-03-01
Direct Ampk Activators
App 20180051006 - Shaw; Simon ;   et al.
2018-02-22
Axl Inhibitors For Use In Combination Therapy For Preventing, Treating Or Managing Metastatic Cancer
App 20170042891 - Hitoshi; Yasumichi ;   et al.
2017-02-16
Methods for using carboxamide, sulfonamide and amine compounds
Grant 9,511,058 - Payan , et al. December 6, 2
2016-12-06
Ampk-activating Heterocyclic Compounds And Methods For Using The Same
App 20160229838 - Goff; Dane ;   et al.
2016-08-11
Whole blood assay for measuring AMPK activation
Grant 9,383,362 - Markovtsov , et al. July 5, 2
2016-07-05
AMPK--activating heterocyclic compounds and methods for using the same
Grant 9,266,856 - Goff , et al. February 23, 2
2016-02-23
Whole Blood Assay for Measuring AMPK Activation
App 20150168408 - Markovtsov; Vadim ;   et al.
2015-06-18
Whole blood assay for measuring AMPK activation
Grant 9,005,909 - Markovtsov , et al. April 14, 2
2015-04-14
Methods For Using And Biomarkers For Ampk-activating Compounds
App 20150087673 - Hitoshi; Yasumichi ;   et al.
2015-03-26
AMPK-activating heterocyclic compounds and methods for using the same
Grant 8,987,303 - Goff , et al. March 24, 2
2015-03-24
AMPK-activating heterocyclic compounds and methods for using the same
Grant 8,980,921 - Goff , et al. March 17, 2
2015-03-17
Methods for Using Carboxamide, Sulfonamide and Amine Compounds
App 20140323460 - Payan; Donald ;   et al.
2014-10-30
Ampk-activating Heterocyclic Compounds And Methods For Using The Same
App 20140315884 - Goff; Dane ;   et al.
2014-10-23
AMPK-activating heterocyclic compounds and methods for using the same
Grant 8,809,370 - Goff , et al. August 19, 2
2014-08-19
Methods for using carboxamide, sulfonamide and amine compounds
Grant 8,796,254 - Payan , et al. August 5, 2
2014-08-05
Substituted pyridine, pyridazine, pyrazine and pyrimidine compounds and methods for using the same
Grant 8,791,136 - Goff , et al. July 29, 2
2014-07-29
Axl Inhibitors For Use In Combination Therapy For Preventing, Treating Or Managing Metastatic Cancer
App 20130338161 - Hitoshi; Yasumichi ;   et al.
2013-12-19
Ampk-activating Heterocyclic Compounds And Methods For Using The Same
App 20130267702 - Goff; Dane ;   et al.
2013-10-10
Ampk-activating Heterocyclic Compounds And Methods For Using The Same
App 20130267701 - Goff; Dane ;   et al.
2013-10-10
Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer
Grant 8,546,433 - Hitoshi , et al. October 1, 2
2013-10-01
Ampk-activating Heterocyclic Compounds And Methods For Using The Same
App 20130203987 - Goff; Dane ;   et al.
2013-08-08
Whole Blood Assay For Measuring Ampk Activation
App 20120178098 - Markovtsov; Vadim ;   et al.
2012-07-12
Substituted Pyridine, Pyridazine, Pyrazine And Pyrimidine Compounds And Methods For Using The Same
App 20120028954 - Goff; Dane ;   et al.
2012-02-02
Methods for Using Carboxamide, Sulfonamide and Amine Compounds
App 20110245222 - Payan; Donald ;   et al.
2011-10-06
shRNA library
Grant 7,863,222 - Payan , et al. January 4, 2
2011-01-04
Axl Inhibitors For Use In Combination Therapy For Preventing, Treating Or Managing Metastatic Cancer
App 20100196511 - Hitoshi; Yasumichi ;   et al.
2010-08-05
shRNA library
App 20100029505 - Payan; Donald G. ;   et al.
2010-02-04
Methods for Treating Renal Tumors Using 2, 4-Pyrimidinediamine Drug and Prodrug Compounds
App 20090048214 - Hitoshi; Yasumichi ;   et al.
2009-02-19
NP95: methods of assaying for cell cycle modulators
Grant 7,482,130 - Hitoshi , et al. January 27, 2
2009-01-27
Methods of Treating Cell Proliferative Disorders
App 20090012045 - Hitoshi; Yasumichi ;   et al.
2009-01-08
SAK: modulation of cellular proliferation for treatment of cancer
Grant 7,413,870 - Hitoshi , et al. August 19, 2
2008-08-19
MRE 11: modulation of cellular proliferation
Grant 7,358,040 - Hitoshi , et al. April 15, 2
2008-04-15
Np95: Methods Of Assaying For Cell Cycle Modulators
App 20070128673 - Hitoshi; Yasumichi ;   et al.
2007-06-07
Cell cycle targets and peptides
App 20060216299 - Hitoshi; Yasumichi ;   et al.
2006-09-28
NP95: methods of assaying for cell cycle modulators
Grant 7,090,990 - Hitoshi , et al. August 15, 2
2006-08-15
Methods and compositions for screening for altered cellular phenotypes
App 20060147978 - Lorens; James ;   et al.
2006-07-06
Methods and compositions for screening for altered cellular phenotypes
Grant 7,056,687 - Lorens , et al. June 6, 2
2006-06-06
Methods of assaying for cell cycle modulators
App 20060051755 - Hitoshi; Yasumichi ;   et al.
2006-03-09
LETM1: modulators of cellular proliferation
Grant 7,005,254 - Demo , et al. February 28, 2
2006-02-28
Modulators of cellular proliferation
App 20040126784 - Hitoshi, Yasumichi ;   et al.
2004-07-01
Toso
Grant 6,727,350 - Nolan , et al. April 27, 2
2004-04-27
NP95: methods of assaying for cell cycle modulators
App 20030194713 - Hitoshi, Yasumichi ;   et al.
2003-10-16
BAP-1: methods of assaying for cell-cycle modulators
App 20030195138 - Hitoshi, Yasumichi ;   et al.
2003-10-16
LETM1: modulators of cellular proliferation
App 20030040001 - Demo, Susan ;   et al.
2003-02-27
MRE11: modulation of cellular proliferation
App 20030027167 - Hitoshi, Yasumichi ;   et al.
2003-02-06
SAK: modulation of cellular proliferation for treatment of cancer
App 20030027756 - Hitoshi, Yasumichi ;   et al.
2003-02-06
Methods and compositions for screening for altered cellular phenotypes
App 20030022196 - Lorens, James ;   et al.
2003-01-30
Toso
App 20020177565 - NOLAN, GARRY P. ;   et al.
2002-11-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed